Fact CheckerSign in

NCT02750319Active, not recruitingPhase 3

Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery

A Randomized, Double-Blind, Controlled Trial of Combined Amiodarone and N-Acetylcysteine Versus Amiodarone Plus Placebo for the Prevention of Atrial Fibrillation in High Risk Patients Undergoing Thoracic Surgery

Source: ClinicalTrials.gov · Last updated 19 May 2026

Brief summary (registry, in English)

This trial will be comparing the combination of amiodarone and NAC (n=122) to amiodarone alone and NAC matched placebo (n=122) to determine the rates with which sustained (lasting \>30 seconds) or clinically significant POAF is reduced in high risk patients within 7 days after major thoracic surgery.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
184 (actual)
First submitted
21 Apr 2016
Start date
1 Apr 2016
Primary completion date
30 Apr 2027
Lead sponsor
Memorial Sloan Kettering Cancer Center
NCT number
NCT02750319

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 184
  • From 1 Apr 2016 to the primary completion date, 30 Apr 2027
  • 9 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients already taking class Ic or III antiarrhythmic drugs.

Other illness

  • Patients with hypersensitivity to amiodarone or NAC.

Lab values

  • Hepatic insufficiency (≤2 times the upper normal limit of transaminase levels).
  • Renal insufficiency (creatinine ≥2.0 mg/dl).

Other

  • Patients scheduled for extrapleural pneumonectomy.
  • Hemodynamically unstable patients (not in cardiogenic shock or having an acute MI).
  • Patients with 2nd or 3rd degree atrioventricular (AV) block.
  • Known pregnancy.

Who the study is looking for

  • Patients ≥18 years old scheduled for elective thoracic surgery (segmentectomy, lobectomy or bi-lobectomy, pneumonectomy or esophagectomy) and meeting one of the four following risk criteria:
    • 1\. Female \& BNP ≥ 25pg/ml (no age limit)
    • 2\. Male gender \<75 \& BNP ≥ 25pg/ml
    • 3\. Male- age ≥75 (No BNP limit)
    • 4\. History of prior AF
  • Patients in sinus rhythm.
  • Patients with stable respiratory status (no respiratory distress).
  • Patients capable of providing written, informed consent.

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (9)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Memorial Sloan Kettering Basking Ridge (Consent Only)
Coordinator of this site? Confirm its status
Basking RidgeUnited StatesUnknown status
Memorial Sloan Kettering Commack (Consent only)
Coordinator of this site? Confirm its status
CommackUnited StatesUnknown status
Memorial Sloan Kettering Westchester (Consent only)
Coordinator of this site? Confirm its status
HarrisonUnited StatesUnknown status
Memorial Sloan Kettering Monmouth (Consent Only)
Coordinator of this site? Confirm its status
MiddletownUnited StatesUnknown status
Memorial Sloan Kettering Bergen (Consent Only)
Coordinator of this site? Confirm its status
MontvaleUnited StatesUnknown status
Memorial Sloan-Kettering Cancer Center
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status
Memorial Sloan Kettering Rockville Centre (Consent only)
Coordinator of this site? Confirm its status
Rockville CentreUnited StatesUnknown status
University of Washington School of Medicine in St. Louis
Coordinator of this site? Confirm its status
St LouisUnited StatesUnknown status
Memorial Sloan Kettering Nassau (Consent Only)
Coordinator of this site? Confirm its status
UniondaleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.